Label: CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL ACNE TREATMENT- salicylic acid gel
- NDC Code(s): 49967-172-01
- Packager: L'Oreal USA Products Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 31, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
- When using this product
- Keep out of reach of children.
-
Directions
• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day - Other information
-
Inactive ingredients
water, glycerin, sodium hydroxide, glycolic acid, lactic acid, niacinamide, ceramide NP, ceramide AP, ceramide EOP, carbomer, cetearyl alcohol, behentrimonium methosulfate, triethyl citrate, sodium hyaluronate, sodium lauroyl lactylate, cholesterol, chlorphenesin, disodium EDTA, hydroxypropyl guar, caprylyl glycol, xanthan gum, phytosphingosine, benzoic acid
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL ACNE TREATMENT
salicylic acid gelProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49967-172 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid 20 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) SODIUM HYDROXIDE (UNII: 55X04QC32I) GLYCOLIC ACID (UNII: 0WT12SX38S) LACTIC ACID (UNII: 33X04XA5AT) NIACINAMIDE (UNII: 25X51I8RD4) CERAMIDE NP (UNII: 4370DF050B) CERAMIDE AP (UNII: F1X8L2B00J) CERAMIDE 1 (UNII: 5THT33P7X7) CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61) TRIETHYL CITRATE (UNII: 8Z96QXD6UM) HYALURONATE SODIUM (UNII: YSE9PPT4TH) SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO) CHOLESTEROL (UNII: 97C5T2UQ7J) CHLORPHENESIN (UNII: I670DAL4SZ) EDETATE DISODIUM (UNII: 7FLD91C86K) GUARAPROLOSE (1300 MPA.S AT 1%) (UNII: 1530WMS90S) CAPRYLYL GLYCOL (UNII: 00YIU5438U) XANTHAN GUM (UNII: TTV12P4NEE) PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q) BENZOIC ACID (UNII: 8SKN0B0MIM) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49967-172-01 1 in 1 CARTON 05/18/2021 1 40 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M006 05/18/2021 Labeler - L'Oreal USA Products Inc (002136794) Establishment Name Address ID/FEI Business Operations L'OREAL USA PRODUCTS, INC. 624244349 manufacture(49967-172) , pack(49967-172)